News
-
Glac Biotech Achieves Another Milestone: Probiotic Strain CP-9 Receives U.S. FDA GRAS Certification
2025/09/17 -
2025.08.07 Taiwan’s First GRAS-Certified Probiotic — Glac Biotech’s MP108 Achieves Historic U.S. FDA Recognition
2025/08/08 -
2025.7.9 Glac Biotech Donates Probiotics to Support Vulnerable Communities in Changhua
2025/08/08 -
2025.1.10 Totipro® Wins National Innovation Awards — Redefining the Future of Postbiotics
2025/08/08 -
2024.9.5 Glac Biotech Brings Hope to Guangfu Elementary — A Story of Warmth in the Hills of Nantou
2025/08/08 -
2024.5.31 Glac Biotech’s Probiotic Business Set to Break NT$500 Million in Revenue — A Story of Growth, Strategy, and Gl
2025/08/08 -
2024.12.17 Glac Biotech × Public Good — Supporting Whole-Person Education and Building Dreams for the Next Generation
2025/08/07 -
2024.7.23 Glac Biotech Unveils Next-Generation Probiotic Technology and Brain Health Innovations
2025/08/08 -
2024.4.2 Glac Biotech’s Probiotic Strains F-1 & CP-9 — The Secret Engine Powering Global OEM Success
2025/08/07